Vincerx Pharma (VINC) PT Lowered to $2 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Jonathan Chang lowered the price target on Vincerx Pharma (NASDAQ: VINC) to $2.00 (from $4.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
